BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27798116)

  • 1. Most brain disease-associated and eQTL haplotypes are not located within transcription factor DNase-seq footprints in brain.
    Handel AE; Gallone G; Zameel Cader M; Ponting CP
    Hum Mol Genet; 2017 Jan; 26(1):79-89. PubMed ID: 27798116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of computational footprinting methods for DNase sequencing experiments.
    Gusmao EG; Allhoff M; Zenke M; Costa IG
    Nat Methods; 2016 Apr; 13(4):303-9. PubMed ID: 26901649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNase I sensitivity QTLs are a major determinant of human expression variation.
    Degner JF; Pai AA; Pique-Regi R; Veyrieras JB; Gaffney DJ; Pickrell JK; De Leon S; Michelini K; Lewellen N; Crawford GE; Stephens M; Gilad Y; Pritchard JK
    Nature; 2012 Feb; 482(7385):390-4. PubMed ID: 22307276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BinDNase: a discriminatory approach for transcription factor binding prediction using DNase I hypersensitivity data.
    Kähärä J; Lähdesmäki H
    Bioinformatics; 2015 Sep; 31(17):2852-9. PubMed ID: 25957350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explicit DNase sequence bias modeling enables high-resolution transcription factor footprint detection.
    Yardımcı GG; Frank CL; Crawford GE; Ohler U
    Nucleic Acids Res; 2014 Oct; 42(19):11865-78. PubMed ID: 25294828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XL-DNase-seq: improved footprinting of dynamic transcription factors.
    Oh KS; Ha J; Baek S; Sung MH
    Epigenetics Chromatin; 2019 Jun; 12(1):30. PubMed ID: 31164146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Footprinting Analyses from DNase-seq Data to Construct Gene Regulatory Networks.
    Moyano TC; Gutiérrez RA; Alvarez JM
    Methods Mol Biol; 2021; 2328():25-46. PubMed ID: 34251618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DeFCoM: analysis and modeling of transcription factor binding sites using a motif-centric genomic footprinter.
    Quach B; Furey TS
    Bioinformatics; 2017 Apr; 33(7):956-963. PubMed ID: 27993786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution mapping of in vivo genomic transcription factor binding sites using in situ DNase I footprinting and ChIP-seq.
    Chumsakul O; Nakamura K; Kurata T; Sakamoto T; Hobman JL; Ogasawara N; Oshima T; Ishikawa S
    DNA Res; 2013 Aug; 20(4):325-38. PubMed ID: 23580539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide discovery of active regulatory elements and transcription factor footprints in
    Ho MCW; Quintero-Cadena P; Sternberg PW
    Genome Res; 2017 Dec; 27(12):2108-2119. PubMed ID: 29074739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to fine-map genetic associations with lipid levels by combining epigenomic annotations and liver-specific transcription profiles.
    Lo KS; Vadlamudi S; Fogarty MP; Mohlke KL; Lettre G
    Genomics; 2014 Aug; 104(2):105-12. PubMed ID: 24997396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global reference mapping of human transcription factor footprints.
    Vierstra J; Lazar J; Sandstrom R; Halow J; Lee K; Bates D; Diegel M; Dunn D; Neri F; Haugen E; Rynes E; Reynolds A; Nelson J; Johnson A; Frerker M; Buckley M; Kaul R; Meuleman W; Stamatoyannopoulos JA
    Nature; 2020 Jul; 583(7818):729-736. PubMed ID: 32728250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducible inference of transcription factor footprints in ATAC-seq and DNase-seq datasets using protocol-specific bias modeling.
    Karabacak Calviello A; Hirsekorn A; Wurmus R; Yusuf D; Ohler U
    Genome Biol; 2019 Feb; 20(1):42. PubMed ID: 30791920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Scale Analysis of Cell-Specific Regulatory Codes Using Nuclear Enzymes.
    Baek S; Sung MH
    Methods Mol Biol; 2016; 1418():225-40. PubMed ID: 27008018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the identification of potential regulatory variants within genome wide association candidate SNP sets.
    Chen CY; Chang IS; Hsiung CA; Wasserman WW
    BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wellington: a novel method for the accurate identification of digital genomic footprints from DNase-seq data.
    Piper J; Elze MC; Cauchy P; Cockerill PN; Bonifer C; Ott S
    Nucleic Acids Res; 2013 Nov; 41(21):e201. PubMed ID: 24071585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors.
    Wang J; Zhuang J; Iyer S; Lin X; Whitfield TW; Greven MC; Pierce BG; Dong X; Kundaje A; Cheng Y; Rando OJ; Birney E; Myers RM; Noble WS; Snyder M; Weng Z
    Genome Res; 2012 Sep; 22(9):1798-812. PubMed ID: 22955990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-scale mapping of DNase I hypersensitivity.
    John S; Sabo PJ; Canfield TK; Lee K; Vong S; Weaver M; Wang H; Vierstra J; Reynolds AP; Thurman RE; Stamatoyannopoulos JA
    Curr Protoc Mol Biol; 2013 Jul; Chapter 27():Unit 21.27. PubMed ID: 23821440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The native cistrome and sequence motif families of the maize ear.
    Savadel SD; Hartwig T; Turpin ZM; Vera DL; Lung PY; Sui X; Blank M; Frommer WB; Dennis JH; Zhang J; Bass HW
    PLoS Genet; 2021 Aug; 17(8):e1009689. PubMed ID: 34383745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.
    Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.